U.S. Markets open in 4 hrs, 24 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,058.64 | 150.25 | 1.52% |
| NASDAQ | 2,150.87 | 24.82 | 1.17% |
| S&P 500 | 1,070.52 | 13.78 | 1.30% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 1.60 03:26 PM EST | |
|---|---|---|
| Day High | 1.70 01:20 PM EST |
|
| Range | 0.10 |
| Volume | 1.33 M | |
|---|---|---|
| 30-Day Avg Vol | 3.29 M |
|
| Difference | -59.41% |
| Market Cap | 58.03 M | |
|---|---|---|
| Mkt Cap Chg | 699,230 |
| Shares Out | 34.96 M | |
|---|---|---|
| % Shrs Traded | 3.82% | |
| 1yr EPS Est | -1.069 |
| 52-Wk Low | 1.50 | |
|---|---|---|
| 52-Wk High | 9.14 |
|
| Range | 7.64 |
| Prev Close | 1.64 2/8/10 | |
|---|---|---|
| Today's Open | 1.66 | |
| Change | 1.22% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 7.16 M |
| Revenue (LFY) | 0 | |
|---|---|---|
| Earnings (LFY) | -48.56 M | |
| Earnings (MRQ) | -9.88 M | |
| Next Earn Est | -0.244 | |
| Next Earnings | 03/15/2010 |
|
| EPS (TTM) | -1.36 | |
| 1yr EPS Growth | 21.40% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -1.00 | |
| PEG Ratio | — | |
| Return on Equity | -77.35 | |
| Beta | 1.22 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Poniard Pharmaceuticals is taking a stab at developing better cancer therapies. After abandoning its radiopharmaceuticals research, the firm is now focused on picoplatin, an injectable chemotherapy that ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.244 3/15/10 | — — |
—
—
|
| Last Quarter | -0.293 9/30/09 | -0.29 9/30/09 |
0.003
Beat
|
| 2 Quarters Ago | -0.343 6/30/09 | -0.28 6/30/09 |
0.063
Beat
|
| Quarterly - 09/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 0.00 | 0.00 |
| Gross Profit | -4.58 M | -36.32 M |
| Operating Income | -9.20 M | -49.16 M |
| Net Income | -9.88 M | -48.56 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts